These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21622243)

  • 1. Finding the root of the problem: the quest to identify melanoma stem cells.
    Abel EV; Aplin AE
    Front Biosci (Schol Ed); 2011 Jun; 3(3):937-45. PubMed ID: 21622243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease.
    Sharma BK; Manglik V; Elias EG
    J Surg Res; 2010 Sep; 163(1):e11-5. PubMed ID: 20638684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
    Fusi A; Reichelt U; Busse A; Ochsenreither S; Rietz A; Maisel M; Keilholz U
    J Invest Dermatol; 2011 Feb; 131(2):487-94. PubMed ID: 20882037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
    Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
    Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface Nestin is a biomarker for glioma stem cells.
    Jin X; Jin X; Jung JE; Beck S; Kim H
    Biochem Biophys Res Commun; 2013 Apr; 433(4):496-501. PubMed ID: 23524267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
    Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
    Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD133 and other putative stem cell markers in uveal melanoma.
    Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
    Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.
    Kim HS; Yoo SY; Kim KT; Park JT; Kim HJ; Kim JC
    Int J Clin Exp Pathol; 2012; 5(8):754-61. PubMed ID: 23071857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
    Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
    Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the clinical value of cancer stem cell markers in gliomas?
    Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
    Sabet MN; Rakhshan A; Erfani E; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.
    Sherman JH; Redpath GT; Redick JA; Purow BW; Laws ER; Jane JA; Shaffrey ME; Hussaini IM
    J Neurosci Methods; 2011 May; 198(1):99-102. PubMed ID: 21402102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human breast and melanoma cancer stem cells biomarkers.
    La Porta CA; Zapperi S
    Cancer Lett; 2013 Sep; 338(1):69-73. PubMed ID: 22445909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of cancer stem cell markers in sarcomas.
    Veselska R; Skoda J; Neradil J
    Klin Onkol; 2012; 25 Suppl 2():2S16-20. PubMed ID: 23581011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stem cell marker nestin predicts poor prognosis in human melanoma.
    Piras F; Perra MT; Murtas D; Minerba L; Floris C; Maxia C; Demurtas P; Ugalde J; Ribatti D; Sirigu P
    Oncol Rep; 2010 Jan; 23(1):17-24. PubMed ID: 19956860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.
    Wan Y; Fei XF; Wang ZM; Jiang DY; Chen HC; Yang J; Shi L; Huang Q
    Chin J Cancer; 2012 Apr; 31(4):207-14. PubMed ID: 22360855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
    Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
    Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell markers in gliomas.
    Dell'Albani P
    Neurochem Res; 2008 Dec; 33(12):2407-15. PubMed ID: 18493853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.